A beneficial effect of insulin in reducing cere bral ischemic damage has been recently demonstrated, and a direct central mechanism of insulin action in cere bral ischemia has been proposed. To test the hypothesis that one of the neuroprotective mechanisms of insulin action involves a direct interaction with CNS tissue via a growth factor effect, a continuous intraventricular infu sion of two doses of insulin and of insulin-like growth factor I (IGF-I) was given to fed Wistar rats subjected to 10 min, 15 s of transient forebrain ischemia. Quantitative neuropathology after I-week survival showed that low dose insulin (7 IV/rat/day; n = 10) reduced selective ne crosis in the striatum (p = 0.015) and one level of the hippocampus (p = 0.023) as compared with animals in fused with phosphate-buffered saline (200 1J.1Irat!day; n = 8). IGF-I (50 lJ.g/rat/day; n = 8) significantly amelio-
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biological activity in the CNS. They are structurally related polypeptides, believed to have overlapping biological functions (Hill et aI., 1988; Knusel et aI., 1990) . Central receptors for both insulin and insulin like growth factors have been shown to exist in the brain (Havrankova and Roth, 1978; Hill et aI., 1986; Duffy et aI., 1988; Adem et aI., 1989; Araujo et aI., 1989; Shemer et aI., 1989) . Insulin and IGF-1 have been shown to promote neuronal survival, neurite outgrowth, and gene expression in vitro (Bhat, 1983; Knusel et aI., 1990) . Insulin and IGF-1 may have a salubrious effect in ischemic injury. Using intraventricular injection of IGF-1 in vivo, Gluck man and associates (1992) showed that IGF-1 may have therapeutic potential for hypoxic/ischemic brain injury in infant rats. Recent findings from our laboratory (Voll and Auer, 1991) illustrate that in transient forebrain ischemia, peripherally adminis tered insulin may attenuate ischemic brain damage independently of its hypoglycemic effect, raising the possibility that insulin may reduce brain damage through a direct central effect.
The present study was designed to test the hy-pothesis that a direct central insulin action on brain tissue exists in antiischemic neuroprotection with insulin, as well as the possible involvement of growth factor receptors of the IGF type in the neu roprotective mechanism.
MATERIALS AND METHODS
A total of 46 male Wistar rats (Charles River Breeding Center, St. Constant, Quebec) were used. To maintain optimum stability of the IGF within the minipumps at body temperature, the pH of the carrier solution was ad justed to be as acidic as possible without harming the brain. Pilot experiments (n = 6) revealed no histologic or behavioral effects of slow intraventricular infusion of so lution at a pH of 4.0, and hence the osmotic minipumps (Alzet mini-osmotic pump, capacity 200 ILl; Alza Corp., Palo Alto, CA, U.S.A.) were loaded with solutions at this pH for all groups. Insulin and IGF-l were diluted in phos phate-buffered saline (PBS) at a pH of 4.0, and the infu sion was begun 30 min prior to ischemia.
Thirty-four fed rats (245-300 g) were randomly divided into four groups. The intraventricular infusion consisted of either PBS (200 ILlfrat/day; CTRL; n = 8), IGF-l (Re combinant Human Insulin-Like Growth Factor-I; Genen tech, South San Francisco, CA, U.S.A.; 1.75 mg/ml, 350 ILg in 200 ILl; n = 8), low-dose insulin (crystalline biosyn thetic human insulin; Eli Lilly, Indianapolis, IN, U.S.A.; 7 IV/rat/day; INS\ow; n = 10), or high-dose insulin (23 IV/rat/day; INShigh; n = 8).
Anesthesia was induced in all experiments with an ini tial concentration of 4% halothane in a mixture of 40% O2/60% N20 for 5 min. The rats were then intubated with PE-240 polyethylene tubing under the guidance of a fi beroptic light source (Intralux 4000; Volpi, Switzerland) and maintained on 1 % halothane using a Starling-type ventilator throughout the surgery.
The head was placed in a stereotaxic instrument (model ST-7; Narishige, Tokyo, Japan), and a skin incision was made to expose the skull in the midline. The exposure was cleaned with H202 and sterilized with 95% ethanol. A dental drill with a diamond bit was used to place a burr hole 1.2 mm posterior and 1.5 mm lateral to bregma. The cannula probe tip was inserted to a depth of 4 mm and was stabilized with methyl methacrylate glue and dental cement. PBS, insulin, and IGF-l were connected to the osmotic minipumps for continuous delivery of solution for 7 days at a nominal pumping rate of 1.0 ILlfh into the left lateral ventricle. To verify that infusions through the cannula actually reached the ventricular CSF, six rats were given Evans Blue dye in a pilot study using this procedure. Dye was seen to be delivered solely to the lateral ventricle in all six rats.
The animals were then removed from the stereotaxic instrument and the ventral tail artery was cannulated with PE-50 polyethylene tubing attached to a Statham trans ducer (Gould P50; Cleveland, OH, U.S.A.), allowing MABP to be automatically recorded by computer every 5 s. The bipolar interhemispheric EEG was monitored and intermittently recorded. The lateral tail vein was cannu lated with PE-50 polyethylene tubing and connected to a compact syringe pump (Harvard model 975, South Natick, MA, U.S.A.) infusing 0.9% normal saline at the infusion rate of 4 mlJkg/h. Core temperature was main- 1994 tained at 3rC using a thermistor-regulated servo controlled heating blanket (Harvard, Edenbridge, Kent, England). Head temperature was monitored separately using a thermometer located in the external auditory me atus and was regulated to 37 ± O.I°C using an overhead heating lamp located symmetrically over the skull vertex. A flexible silicon catheter, having both distal and lateral openings, was positioned via the right jugular vein, with the distal opening located in the inferior vena cava. Blood glucose levels were monitored using glucose oxidase re agent strips and a reflectance glucometer (Ames Co., Mishawaka, IN, U.S.A.). The common carotid arteries were isolated, and blood gases, pH, and blood glucose were measured after a period of to-min stabilization, im mediately before the induction of ischemia. The rats were paralyzed with 0.5 mg i.v. suxamethonium chloride (Sigma, St. Louis, MO, U.S.A.), and halothane was dis continued during the ischemic insult. Cerebral ischemia was induced by bilateral carotid artery clamping in com bination with controlled exsanguination (Smith et aI., 1984) . Mter the carotid artery clamps were applied, blood was rapidly withdrawn via the central venous line into a prewarmed heparinized to-ml syringe until the MABP reached 50 mm Hg. Onset of an isoelectric EEG was used to time the duration of the ischemic period. Blood pres sure was maintained at 50 mm Hg by withdrawal or rein fusion of blood through the central venous catheter. The carotid clamps were released to min, 15 s after the onset of an isoelectric EEG and 1% halothane was restored. Blood glucose and arterial blood gas measurements were repeated 10 min after carotid clamp removal. The dura tion of the entire procedure was -140 min.
Rats from all groups were allowed to survive for 1 week after the operation, and all animals had free access to food and water in the postoperative period. Under 2% halothane anesthesia, transcardiac perfusion was per formed for 1 min with saline, followed by 4% formalde hyde, phosphate-buffered to pH 7.30. Blood was with drawn from the heart and the blood glucose was mea sured again just before the perfusion. The brains were removed the following day, processed in graded ethanols and xylol, and embedded in paraffin. Serial sectioning at 8-lLm thickness was done at 250-lLm intervals. Sections were stained with hematoxylin and eosin.
Neuronal necrosis was assessed by direct visual count ing of acidophilic neurons, established as being necrotic in a previous study (Auer et aI., 1985) , and damage was scored as follows: In the cerebral cortex, where the total cell counts per section were not available, the absolute number of acidophilic neurons was counted. In the stria tum, one 630-lLm-diameter (0.31-mm 2 ) dorsolateral mi croscopic field was counted bilaterally at the coronal level of the septal nuclei at their widest point (bregma -0.3 mm) (Paxinos and Watson, 1982) , and the propor tion of necrotic neurons was calculated. In the hippocam pus, the percentage of necrotic neurons in CAl was cal culated from the known total neuronal counts (Auer et aI., 1984) for each of six septotemporal levels. Control counts were done to assess intraobserver and interob server variability, which was �5%.
Both neuronal necrosis and physiological variables, in cluding weight and duration of the operating time, were assumed to be parametric. However, the percentage val ues were treated as proportions, and hence statistical analysis of these variables was done on arcsine transformed data (Sokal and Rohlf, 1981) . Groups were compared using one-way analysis of variance, with Scheffe's test for multiple comparison between groups. All data were summarized as means ± SD. Significance was assumed at p < 0.05.
RESULTS
The body weight, and hence age, were compara ble (p > 0.05) in the four groups. Physiological pa rameters are shown in Table 1 . The duration of sur gery (152 min) was also similar between groups. However, the CTRL group lost weight (see Table  1 ), whereas the three treated groups, especially the INShi g h group, gained weight significantly (p < 0.01). Also, the preischemic glucose level of the INShi g h group was significantly lower than that of the three other groups (p < 0.01), which did not differ significantly among themselves. However, the differences were abolished postischemia (p > 0.05), but reappeared later at the time of perfusion (p < 0.05). Preischemic and postischemic head and body temperatures did not differ significantly among the groups, and there were no significant differences in the remaining physiologic parameters (see Table 1 ).
Histopathological study showed that CTRL rats had the most severe damage in all three areas ex amined. Neocortical examination (Fig. 1) showed that the number of necrotic neurons in CTRL was 696 ± 377 compared with 374 ± 373 in the IGF group, 335 ± 265 in the INS\ow group, and 145 ± 185 in the INShi g h group (p < 0.0108). Scheffe's test showed that the significant difference was between IGF-l Low insulin High insulin (n = 8) (n = 10) (n = 8) 141 ± 8.3 151 ± 17.9 147.0 ± 13.9 270 ± 12.6 270 ± 11.4 267.5 ± 13.4 8.4 ± 18.9
1.5 ± 35.7 23.9 ± 13.4a
1l.8 ± 2.0 10.9 ± 1.8 7.81 ± 1.9b 7.35 ± 0.2 7.35 ± 0.5 7.37 ± 0.02 38.1 ± 3.0 37.0 ± 5.3 37.0 ± 3.2 125.1 ± 3.9
125.3 ± 3.4 124.1 ± 3.1 36.9 ± 0.8 36.9 ± 0.1 36.9 ± 0.1 37.1 ± 0.5 37 ± 0.1 37.08 ± O.lb 77.1 ± 6.7 77.7 ± 6.3 79.8 ± 7.5
13.2 ± 1.8 14.2 ± 2.0 10.5 ± 5.1 7.29 ± 0.02 7.32 ± 0.04 7.29 ± 0.05 40.0 ± 2.7 39.1 ± 5.2 41.5 ± 5.5 126.9 ± 2.9 127.7 ± 5.4 125 ± 7.4 36.9 ± 0.1 36.9 ± 0.1 36.9 ± 0.1 36.9 ± 0.1 36.9 ± 0.1 36.9 ± 0.5 87.5 ± 5.0 86.8 ± 5.0 86 ± 5.4 12.2 ± 2.1 1l.8 ± 3.7 4.3 ± 2.4b
the CTRL and INShi g h groups (p < 0.013), the other differences not reaching statistical significance. Al though there was a trend for both IGF and INS\ow to have fewer necrotic neurons, this did not achieve statistical significance among any other pairs of si multaneously compared groups (Fig. 1) . Striatal pa thology showed that the most severe neuronal ne crosis was 58 ± 35% in the CTRL group, with 21 ± 33, 12 ± 30, and 0.5 ± 1.4% necrosis in IGF, INS \ow , and INShi g h groups, respectively (p < 0.0014). Scheffes test showed that the significant differences were between the CTRL group and both INS\o w (p < 0.015) and INShigh (p < 0.003) but not between the CTRL and IGF group (Fig. 2) . Hippo campal pathology showed that INShigh had the least damage at all six levels (Fig. 3) . IGF had a signifi cant neuroprotective effect at four levels and INS\ ow at one hippocampal level (Fig. 3) .
DISCUSSION
Evidence has accrued that insulin-induced hypo glycemia is beneficial in both global ischemia (LeMay et ai., 1988; Fukuoka et ai., 1989; Strong et ai., 1990) and focal ischemia (Warner et ai., 1992; Hamilton et ai., 1993) . However, it is uncertain whether insulin ameliorates brain damage solely via peripheral hypoglycemia or whether it acts directly on brain tissue. Recent studies from our laboratory show that in the two-vessel occlusion model of tran sient forebrain ischemia (Smith et ai., 1984) , insulin attenuates ischemic brain damage independently of its hypoglycemic effect (Voll and Auer, 1991) . This suggests that insulin might exert its neuroprotective effect via direct contact with the CNS, possibly me diated via the IGF-1 receptor.
Findings from this study demonstrate that IGF-l itself exerts a weak neuroprotective effect, weaker than insulin itself. Low-dose insulin, in turn, showed a weaker neuroprotective effect than the more robust protection seen with high-dose insulin. The latter may be explained by the reduction in blood sugar that was observed to accompany cen tral administration of high-dose insulin. Although the reduction in blood glucose was only 4 mM, i.e., from 11.8 to 7.8 mM, blood glucose variations such as this can influence ischemic brain damage: A re- cent study of insulin in focal ischemia demonstrated that variation of blood sugar values within the nor mal range can influence the degree of ischemic ne crosis (Hamilton et aI., 1993) . Even the low-dose insulin used in the present study might have caused a small change in peripheral glucose flux, insuffi cient to lower peripheral blood glucose levels. However, the fact that IGF-1, which is devoid of any effect on peripheral blood glucose levels, had an effect in this study argues against a mechanism based solely on these compounds altering glucose flux. Rather, the present results argue for operation of both peripheral and central mechanisms.
Both insulin and IGF receptors exist centrally (Baskin et aI., 1987 (Baskin et aI., , 1988 . Insulin and IGF-1 have differing and reciprocal affinities for insulin and IGF receptors. It has been suggested that insulin is at least 10-fold less potent than IGF-1 at growth factor receptors (Ullrich et aI., 1986) . Therefore, with respect to potency at the IGF-1 receptor, 23 IU (874 f.Lg) of insulin is equipotent to 50 f.Lg of IGF-l. Both these doses were found to be effective in re ducing brain damage in our experiments. IGF-1 was less effective than high-dose insulin, indicating that a growth factor effect is only one of the mechanisms by which insulin can reduce brain damage.
Convincing in vitro evidence for a neuroprotec tive effect of IGF-1 in the CNS has been presented (Ang et aI., 1992; Cheng and Mattson, 1992) , an effect possibly mediated by living astrocytes (Gluckman et aI., 1992) . However, in the present study IGF-1 significantly ameliorated the hippo campal damage at only four of six levels, and not significantly in cortex or striatum. This may be ac counted for by the different distribution of recep tors in these brain areas. Although some discrep ancy exists in the literature concerning the distribu tion of IGF-1 receptors or binding sites (Baskin et ai., 1988) , it is generally believed that IGF-1 recep tors are enriched in the circumventricular organs, choroid plexus, hypothalamus, cerebellum, and ol factory bulb. The highest receptor concentration appears in fetal or perinatal life, playing an impor tant role in regulating growth, development, and metabolism (Adamo et ai., 1989; Bartlett et ai., 1991) . In adult rats, autoradiographic study of brain slices shows that IGF-1 receptors are most concen trated in neocortex and hippocampus (Araujo et aI., 1989) . In human brain studied by quantitative 1251_ IGF-1 autoradiography, the highest densities of IGF-1 receptors were found in the hippocampus, amygdala, and parahippocampal gyrus (Adem et ai., 1989) . Neuroprotection by a single postischemic intraventricular injection of IGF-1 was demon strated in adult rats by Gluckman and colleagues FIG. 3. Percentage selective necrosis in CA, pyramidal neurons (left) at six coro nal levels in the brain (right). Damage in the high-dose group is significantly less severe than that in controls at all levels (p < 0.0001, 0.01, 0.02, 0.05, 0.05, 0.007). Level 1 alone is less damaged (p < 0.02) in the group given low-dose insulin, but damage at levels 1 (p < 0.007), 2, 3, and 4 is mitigated in the group receiving insu lin-like growth factor 1 (IGF-1) (*p < 0.05, **p < 0.0001). (1992). They found reduced neuronal loss in the ce rebral cortex and dentate gyrus, but not in the hip pocampus.
The degree of neuroprotection seen in the present study was modest compared with that obtained us ing peripheral administration of insulin in our pre vious studies (V oIl and Auer, 1988 and Auer, , 1991 Voll et aI., 1989) . One explanation might be that insulin has the greatest central neuroprotective effect when it gains access to brain via the capillaries, which are spe cially equipped with an insulin transporter (Duffy and Pardridge, 1987; Duffy et aI., 1988) . Intraven tricular infusion of insulin may be a relatively poor way to deliver insulin to brain parenchyma from a therapeutic standpoint, since access to tissue re quires upstream diffusion against the normal flow of interstitial fluid from brain to CSF. In this regard, it is of interest that low-dose, centrally administered insulin (7 IV/rat/day) showed less neuroprotection in the present study than equivalent or lesser doses of insulin given peripherally Auer, 1988, 1991; Voll et aI., 1989) .
Although some data (Woods et aI., 1979) would suggest that intraventricular insulin should not cause peripheral hypoglycemia, the possibility must be entertained that in the animals receiving high dose, centrally administered insulin, leakage of in sulin into the periphery occurred, with insulin gain ing access to brain via the capillary circulation. This is supported by the modest hypoglycemic effect seen in the high-dose insulin group. Intraventricular insulin is diluted by the CSF and removed from the ventricular system into the venous blood along with the CSF at the rate of � 2 j.Ll/h (Bass and Lundborg, 1973) into the systemic circulation. Although the INSULIN half-life of circulating insulin is only � 10 min com pared with 16 h for IGF-l (Froesch and Zapf, 1985) , continuous infusion would give rise to nonzero steady-state levels, and it is conceivable that some insulin might have reached brain tissue via the nor mal blood circulation, even though it was given cen trally.
These considerations suggest that leakage of in sulin from CSF is minimal or negligible if the con centration of insulin in CSF is low, but enough in sulin could still be released into blood and cause peripheral hypoglycemia when the concentration of insulin in CSF is high. The neuroprotective effect against necrosis seems to be dose dependent and is paralleled by blood glucose levels. This, combined with our previous results in focal ischemia (Hamil ton et aI., 1993) , strongly suggests that peripheral hypoglycemia did play a role in the neuroprotective effect of insulin even through centrally adminis tered.
Insulin infusion into the CSF has been reported to inhibit feeding and result in loss of body weight in baboons (Woods et aI., 1979 (Woods et aI., , 1985 , but our data showed that rats receiving high-dose insulin gained significantly more weight than control animals, sug gesting that the anabolic biological activity of insu lin predominated under our experimental condi tions. Possibly, the gain or loss of the body weight is but one parameter indicating a neuroprotective effect.
The present experiments used central administra tion of insulin and IGF-l to study mechanisms of the neuroprotective effect of insulin. Our result� suggest that, in addition to neuroprotection result ing from lowering of peripheral blood glucose lev-els, a portion of the neuroprotective action of insu lin in reducing ischemic brain damage occurs via the IGF-l receptor.
